(19)
(11) EP 1 200 442 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.08.2003 Bulletin 2003/34

(45) Mention of the grant of the patent:
25.06.2003 Bulletin 2003/26

(21) Application number: 00944129.6

(22) Date of filing: 04.07.2000
(51) International Patent Classification (IPC)7C07D 491/04, A61K 31/551, A61P 25/00
// (C07D491/04, 317:00), C07D243:00
(86) International application number:
PCT/HU0000/074
(87) International publication number:
WO 0100/4122 (18.01.2001 Gazette 2001/03)

(54)

2,3-BENZODIAZEPINE DERIVATIVES

2,3-BENZODIAZEPINDERIVATE

DERIVES DE 2,3-BENZODIAZEPINES


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.07.1999 HU 9902291

(43) Date of publication of application:
02.05.2002 Bulletin 2002/18

(73) Proprietor: Egis Gyogyszergyar Rt.
1106 Budapest (HU)

(72) Inventors:
  • GREFF, Zoltán
    H-1028 Budapest (HU)
  • SZAB , Géza
    H-1054 Budapest (HU)
  • BARK CZY, József
    H-1016 Budapest (HU)
  • R TKAI, Zoltán
    H-1101 Budapest (HU)
  • BLASK , Gábor
    H-1149 Budapest (HU)
  • SIMIG, Gyula
    H-1126 Budapest (HU)
  • GIGLER, Gábor
    H-1119 Budapest (HU)
  • MARTONN MARK , Bernadett
    H-1171 Budapest (HU)
  • L VAY, György
    H-2092 Budakeszi (HU)
  • TIHANYI, Károly
    H-1171 Budapest (HU)
  • EGYED, András
    H-1145 Budapest (HU)
  • SIM , Annamária
    H-1137 Budapest (HU)

(74) Representative: Cabinet Hirsch 
34, Rue de Bassano
75008 Paris
75008 Paris (FR)


(56) References cited: : 
EP-A- 0 492 485
WO-A-95/01357
WO-A-99/07707
WO-A-92/11262
WO-A-97/34878
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).